BGM vs. ZLAB, PTCT, MRUS, ACAD, ACLX, SWTX, AAPG, RNA, RARE, and PTGX
Should you be buying BGM Group stock or one of its competitors? The main competitors of BGM Group include Zai Lab (ZLAB), PTC Therapeutics (PTCT), Merus (MRUS), ACADIA Pharmaceuticals (ACAD), Arcellx (ACLX), SpringWorks Therapeutics (SWTX), Ascentage Pharma Group International (AAPG), Avidity Biosciences (RNA), Ultragenyx Pharmaceutical (RARE), and Protagonist Therapeutics (PTGX). These companies are all part of the "pharmaceutical products" industry.
BGM Group vs. Its Competitors
BGM Group (NASDAQ:BGM) and Zai Lab (NASDAQ:ZLAB) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, profitability, institutional ownership, analyst recommendations, earnings and valuation.
In the previous week, Zai Lab had 15 more articles in the media than BGM Group. MarketBeat recorded 17 mentions for Zai Lab and 2 mentions for BGM Group. Zai Lab's average media sentiment score of 0.29 beat BGM Group's score of -0.27 indicating that Zai Lab is being referred to more favorably in the news media.
41.7% of Zai Lab shares are owned by institutional investors. 58.7% of BGM Group shares are owned by company insiders. Comparatively, 5.0% of Zai Lab shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
BGM Group has higher earnings, but lower revenue than Zai Lab.
BGM Group has a beta of 1.29, indicating that its share price is 29% more volatile than the S&P 500. Comparatively, Zai Lab has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500.
Zai Lab has a consensus target price of $54.28, suggesting a potential upside of 55.34%. Given Zai Lab's stronger consensus rating and higher possible upside, analysts clearly believe Zai Lab is more favorable than BGM Group.
BGM Group has a net margin of 0.00% compared to Zai Lab's net margin of -60.26%. BGM Group's return on equity of 0.00% beat Zai Lab's return on equity.
Summary
BGM Group and Zai Lab tied by winning 7 of the 14 factors compared between the two stocks.
Get BGM Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for BGM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding BGM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
BGM Group Competitors List
Related Companies and Tools
This page (NASDAQ:BGM) was last updated on 7/9/2025 by MarketBeat.com Staff
Free BGM Stock Alerts